All posts by imreal

Mercy Medical Center Now Offers State of the Art MRI, Provides Greater Accuracy, Clearer Image, More Comfortable for Patients


The Philips Ingenia Elition 3T MRI, the fastest diagnostic magnetic resonance imaging technology available, now at Mercy Medical Center in Baltimore.

The Philips Ingenia Elition 3T MRI, the fastest diagnostic magnetic resonance imaging technology available, now at Mercy Medical Center in Baltimore.

“Patients will appreciate the immersive audio-visual experience, as the 3T MRI provides advanced audio and visual components to allow patients greater control and comfort during their scan.”– Dr. David N. Maine, president and CEO, Mercy Health Services, Mercy Medical Center.

Mercy Medical Center has acquired the Philips Ingenia Elition 3T MRI, the fastest diagnostic magnetic resonance imaging technology available. The 3T MRI was installed and is now operational, said Brad M. Cogan, M.D., Chair of the Department of Radiology at Mercy.

MRI is a technology that uses specially designed strong magnets — between 10,000 and 20,000 times the strength of Earth’s magnetic field — to take images of the organs and structures inside the human body. A tesla is the unit of measurement quantifying the strength of a magnetic field. A 3T MRI generates a magnetic field that is twice as strong as a normal MRI, and 10 to 15 times as strong as open MRI scanners.

“This state-of-the-art diagnostic equipment will provide services for about 9,600 patients per year. The 3T MRI offers greater accuracy and a superior image. Patients will notice significantly less noise than is common in most MRI machines, and will further benefit from reduced time from diagnosis to treatment,” Dr. Cogan said.

“We are extremely pleased to be able to offer this new technology for the benefit of our patients. Patients will appreciate the immersive audio-visual experience, as the 3T MRI provides advanced audio and visual components to allow patients greater control and comfort during their scan,” said Dr. David N. Maine, president and CEO, Mercy Health Services, Mercy Medical Center.

3T MRIs can have a larger and shorter magnet bore, the section of the machine in which the patient will lay still. This means patients with claustrophobia have more space and are less likely to request sedation. Larger patients will have an easier time getting a high quality scan because they can fit more easily into the MRI machine.

MRI scans can vary depending on what is being imaged. The longer it takes to conduct a scan, the greater chance the resulting image will be poor.

“The 3T MRI is faster, so the scan is completed more quickly. That’s important because the longer the patient is in the scanner, the more they may move and the resulting image can degrade,” Dr. Cogan said.

The new machine features dedicated coil technology for extremity imaging of the shoulder, hand, wrist, foot, ankle and knee.

“MRIs are well suited to scan conditions affecting the brain, spine, and musculoskeletal systems. But in addition to that, 3T MRI can scan for new conditions like prostate cancer,” Dr. Cogan said.

“The addition of 3T MRI is a significant upgrade to Mercy’s Imaging department and represents an advancement in technology that benefits patients and clinicians alike,” Dr. Cogan added.

Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is located in downtown Baltimore City, about six blocks from Baltimore’s famed Inner Harbor. A university-affiliated teaching facility, Mercy is a Catholic hospital with a national reputation for women’s health care, orthopedics, and other specialties. Mercy is home to the renowned Weinberg Center for Women’s Health & Medicine, and the $400+ million Mary Catherine Bunting Center. For more information, visit http://www.mdmercy.com, and MDMercyMedia on Facebook and Twitter, or call 1-800-M.D.-Mercy.

-30-

Share article on social media or email:

Alpesh Patel Named One of the Top 10 Inspiring Healthcare Entrepreneurs To Watch In 2023.


Bexcode Services is thrilled to announce that our founder and CEO, Alpesh Patel, has been named one of the top 10 Inspiring healthcare entrepreneurs to watch in 2023 by Entrepreneurs Asia Pacific.

With over 20 Years of experience in the healthcare industry, Alpesh has a proven track record of success in developing innovative solutions to improve patient care and outcomes. Under his leadership, Bexcode Services has grown into a leading technology company focused on developing healthcare technology solutions. As of March, we are starting a new division in the company to provide dedicated technology resources/Staffing to Digital healthcare startups in the USA.

Alpesh’s passion for improving healthcare through technology and his dedication to putting patients first have earned him this well-deserved recognition. He is honored to be included in such an esteemed list of entrepreneurs and is committed to pushing the boundaries of what is possible in healthcare.

We at Bexcode Services are proud to have Alpesh as our leader and look forward to the continued growth and success of the company under his guidance.

For more information about Bexcode Services and our work, please visit our website at https://bexcodeservices.com.

Contact: Umang Sharma

Bexcode Services

pr@bexcodeservices.com

Share article on social media or email:

AHN Opens Dedicated Clinic for Obstetric Patients Experiencing Complex Heart Conditions


News Image

“Those eligible for the newly-launched AHN clinic include any patient exhibiting cardiac symptoms during pregnancy, or patients who wish to conceive who have a prior history of cardiovascular disease,” said Dr. Poornima.

Allegheny Health Network (AHN) announced today it has established a multidisciplinary cardio-obstetrics clinic to care for patients diagnosed with cardiovascular disease who are pregnant, trying to conceive, or in the postpartum period.

Timed to coincide with American Heart Month, today’s announcement is a clinical milestone for the network as it aims to strategically address – and raise awareness of – the notable increase in cardiovascular complications among pregnant population.

The AHN Cardio-Obstetrics Clinic is based in Pittsburgh’s Bloomfield neighborhood (5140 Liberty Ave.) adjacent to AHN West Penn hospital, and is under the direction of physician leads Indu Poornima, MD, director of AHN Women’s Heart Center, and Devon M. Ramaeker, MD, director of AHN Maternal-Fetal Medicine division. Patients can also schedule appointments at AHN Allegheny General and AHN Wexford hospitals.

The clinic’s opening aligns with recent industry recommendations urging an increased focus in cardio-obstetrical health.

“Across the country, maternal-fetal medicine physicians have seen more women entering pregnancy with pre-existing conditions, or women developing complications during gestation,” said Dr. Ramaeker. “Causation varies, but primary drivers include national increases in obesity and age at pregnancy, as well as a notable decrease in access to quality prenatal care.”

Recent studies have shown that rates of preeclampsia – high blood pressure during pregnancy – have grown by upward of 30 percent in the last two decades, impacting U.S. maternal mortality outcomes.

As a result of growing rates of cardiovascular conditions among pregnant populations, the American Heart Association issued a statement in 2021 strongly urging women with cardiovascular disease to seek pre-pregnancy counseling and later be monitored, during and after pregnancy, by a specialized cardio-obstetrics team.

“Those eligible for the newly-launched AHN clinic include any patient exhibiting cardiac symptoms during pregnancy, or patients who wish to conceive who have a prior history of cardiovascular disease,” said Dr. Poornima. “That history might include congenital heart conditions, arrhythmias, or chronic hypertension, among other diagnoses. Once referred, we work as a multidisciplinary care team to help patients along their pregnancy journey and minimize their level of risk as much as possible.”

Cardiologists, maternal-fetal medicine specialists, geneticists, nutritionists, nurses and pharmacists currently comprise the AHN Cardio-Obstetrics clinic and work together to develop a comprehensive approach for managing cardiovascular disease prior to and during pregnancy, during labor and delivery, and throughout the postpartum period.

Patients can expect to work closely with care teams to design and implement a purposeful care pathway to best manage their condition, treat ongoing symptoms, and be closely monitored through the gestational period. Treatment plans will vary, but may include precise medication management, blood pressure management, electrocardiograms, echocardiograms, and prescribed lifestyle modifications.

Maternal mortality rates in the United States continue to rise with Black populations experiencing more than double the number of fatal births compared to white populations with 55.3 in Black pregnant patients versus 17.2 deaths in white pregnant patients, respectively, per every 100,000, according to the Center of Disease Control and Prevention.

In December 2021, AHN announced the First Steps and Beyond program which works to see that all babies born in Allegheny County will celebrate their first birthday by working to reduce Black infant mortality, eliminate preventable sleep-related deaths for infants and mobilize resources for new mothers during their fourth trimester.

For more information on the AHN Cardio-Obstetrics clinic or to make an appointment, call 412-682-2100 and select option “0.”

                                                                             ####

About the Allegheny Health Network:

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 22,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Share article on social media or email:

Owl Be There Featured on Worldwide Business With kathy ireland®


Owl Be There logo

“We’re very excited and honored to see our business opportunity featured on Worldwide Business with kathy ireland, The segment did a wonderful job of communicating the value propositions offered by our franchise opportunity.” — Laura Greenwood, president of Owl Be There

Owl Be There, an emerging franchise concept featuring a network of home-based senior care referral specialists, was recently the subject of a special field report on a recent episode of Worldwide Business with kathy ireland. The show, which airs weekly on the Fox Business Network, features a wide range of in-depth interviews exploring the diverse world of business opportunities and the executives behind the companies and organizations driving today’s innovative growth.

“We’re very excited and honored to see our business opportunity featured on Worldwide Business with kathy ireland,” said Laura Greenwood, president of Owl Be There franchising. “The segment did a wonderful job of communicating the value propositions offered by our franchise opportunity, as well as focusing on the target market we assist – vulnerable seniors and their families who face difficult decisions about the living arrangements of their loved ones.”

Filmed on location at a Maryland-based residential assisted living community that’s previously worked with Owl Be There, founders David and Laura Greenwood explained how their network of referral specialists work with seniors and their families to determine the optimal living arrangements that align closely with their level of care requirements. Thanks to comprehensive training and ongoing support from their corporate office, Owl Be There senior care referral placement specialists are well-prepared to work closely with families in recommending the most suitable outcome among several different levels of senior care facilities. These may include independent or assisted living, memory care communities, and even home-based senior care solutions. As a key assistance provider, the primary mission of Owl Be There’s independent consultants is to improve lives by empowering seniors and their family members to make informed decisions. The full interview segment featuring Owl Be There is available for viewing on the company’s franchising website.

As a franchise opportunity, Owl Be There is a low-cost, low overhead investment with a supportive family based culture, requiring no previous senior care experience to own. The franchise opportunity operates in an industry with extremely high demand, as the number of seniors aged 65 and older grows by 10,000 each day. According to the U.S. Census Bureau, it’s estimated that seniors will top 74 million by the year 2030 – in an assisted living marketplace currently worth $87.4 billion annually in the U.S.

Owl Be There is currently recruiting franchisees in 40 U.S. states. Ideal candidates for the brand’s home-based business opportunity are entrepreneurial-minded individuals with high moral ethical standards, and a strong desire to improve the lives of seniors in their own communities. For further information, please visit http://www.owlbetherefranchise.com or contact Owl Be There’s franchise development team at (218) 695-2273.

About Owl Be There

Owl Be There is a franchise opportunity featuring a network of independent, home-based senior referral specialists who work with seniors and their families to determine the most suitable option for their care level and living arrangements. Owl Be There consultants offer white-glove, concierge-level service at no cost to seniors and their families and are compensated by the brand’s network of senior living facilities and care providers. Owl Be There is currently recruiting new franchise owners in 40 U.S. states, with a standard protected territory size based on a population of 400,000 residents. The franchise opportunity requires no previous senior or healthcare experience and provides both comprehensive training and ongoing support for its network of referral specialists. For more information, please visit http://www.owlbetherefranchise.com.

Share article on social media or email:

SureTest, Inc. and This Week Health Announce Partnership


News Image

“It’s noisy in healthcare — marketing budgets are tight, and decision-makers are hard to reach,” says Russell. “This Week Health’s platform connects organizations like SureTest with the larger health IT community and helps foster meaningful relationships with healthcare decision makers.”

SureTest, Inc., the provider of a turn-key test automation solution to health systems for their EHR and third-party application testing processes, will serve as a sponsoring partner for Health Lyrics and its This Week Health podcast and health IT news site.

“This Week Health, and the education and connections that Bill Russell champions is just the kind of valuable information health IT leaders need to stay on top of industry news and be as effective and innovative as possible in their roles,” says Laura O’Toole, chief executive officer, and SureTest co-founder. “We’re pleased to be able to support such a worthwhile forum for information exchange and relationship building for the next generation of technology leaders in our industry.”

SureTest joins a select group of organizations committed to supporting This Week Health and their mission to keep Health IT staff current and engaged led by founder, and creator Bill Russell. The first event of their partnership commenced with an outstanding 229 CIO Roundtable in January.

“It’s noisy in healthcare — marketing budgets are tight, and decision-makers are hard to reach,” says Russell. “This Week Health’s platform connects organizations like SureTest with the larger health IT community and helps foster meaningful relationships with healthcare decision makers.”

KLAS Research gave SureTest’s test automation solution an A+ across all Key Performance Indicators and a 100% rating in overall customer satisfaction. According to one health system manager, “SureTest’s customer support is really good. We opened a new department, and there was a script we hadn’t provided, but SureTest was very adaptable. Their support and willingness to bend over backward to ensure they are providing the best service they can is phenomenal.”

About This Week Health

This Week Health is dedicated to propelling healthcare forward by raising up the next generation of healthcare leaders. We firmly believe in amplifying the voices of advancement and innovation in health technology to educate and inform progress for health in our communities.

It is becoming increasingly difficult for Health IT professionals to stay up-to-date on the overwhelming amount of industry news, ultimately harming their ability to be effective and innovative in their roles. This Week Health reviews relevant topics and features guest commentary that is quickly and easily consumed each week. By subscribing to our podcast, you and your team can receive the information that equips you to change the healthcare industry.

For more information, visit http://www.ThisWeekHealth.com, or email Hello@thisWeekHealth.com. Subscribe to This Week Health: Conference and This Week Health: NewsRoom to hear our shows.

About SureTest

The company began as a vision of its partners, who are former leaders at Santa Rosa Consulting, a well-established healthcare advisory and consulting group. SureTest provides an intelligent test automation solution to empower health systems to transform their entire EHR and other third-party application testing process and redeem thousands of staff hours annually by allowing SureTest’s dedicated engineers to handle the script development and maintenance. This is truly a turnkey test automation solution allowing healthcare organizations to optimize staff, realize game-changing efficiency, and improve patient care. Our solution precisely emulates the end-user experiences and validates workflow integrity so quickly that it will revolutionize your entire approach to system upgrades and new implementations.

For more information, visit SureTest.health or email connect@SureTest.health. You can also follow us on Twitter and LinkedIn.

Share article on social media or email:



AristaMD Names Eric Urquiza Sr. Vice President of Operations & Client Experience as Company Continues Expansion of Its Care Transition Platform


Eric Urquiza, Sr. Vice President of Operations & Client Experience at AristaMD

Eric Urquiza, Sr. Vice President of Operations & Client Experience at AristaMD

My focus is helping our users meet the needs of patients regardless of their location and care requirements since joining AristaMD. I am excited to enhance our operations in ways that elevate our market-leading healthcare platform and simplify onboarding and usage for our customers. – Eric Urquiza

AristaMD, AristaMD, a digital healthcare company specializing in eConsult and referral management services, announced today the promotion of Eric Urquiza from vice president of client experience to senior vice president of operations and client experience.

Urquiza brings 20 years of experience spanning senior roles in client service, account management and health technology operations. He successfully managed strategic client relationships at AristaMD and introduced data and tools to demonstrate quality and efficiency gains brought about by using the company’s eConsult services.

“It is with great pleasure that I announce Eric Urquiza’s appointment to this key position and as the newest member of our leadership team,” said Brooke LeVasseur, CEO of AristaMD. “Eric’s talent and dedication to customer care made him the clear choice for this role, and I am confident he will create operational efficiencies and further demonstrate the value of our platform to our clients.”

With a remit of creating operational efficiencies around client performance metrics and advancing the organization’s onboarding and training programs, Urquiza will serve as Sr. Vice President of Operations & Client Experience. In this expanded role, he will execute strategic initiatives to improve the clinic experience, increase provider engagement, and grow platform utilization.

“My focus is helping our users meet the needs of patients regardless of their location and care requirements since joining AristaMD,” said Urquiza. “I am excited to enhance our operations in ways that elevate our market-leading healthcare platform and simplify onboarding and usage for our customers.”

Before joining AristaMD, Urquiza served as the Client Services Director and Implementation Director for AccessHope/City of Hope. Previously, he served as Senior Engagement Owner at Cerner Corporation and Project Deployment Manager and Customer Solutions Consultant at Omnicell. He holds a Bachelor of Science in business and a Master of Business Administration from the University of Redlands.

About AristaMD

AristaMD’s care transition solutions, including eConsults and referral management tools, empower providers to conduct electronic physician-to-physician consultations, facilitate the selection and scheduling of in-person specialist visits, trigger automatic follow-up activities critical to patient care, and schedule peer-to-peer reviews for insurance authorization. Electronic referral management and eConsults significantly improve the patient referral process and deliver greater access to timely, equitable, high-quality care. For additional information, visit http://www.aristamd.com, or follow AristaMD on LinkedIn and Twitter.

Share article on social media or email:

Bausch Eye Associates Joins the Growing OCLI Vision Team, Expanding their Pennsylvania Footprint further


“I’m very excited to welcome the exceptional eye doctors and surgeons at Bausch Eye Associates to the OCLI Vision Team.”

OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmologists, optometrists and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia. Bausch Eye Associates is Spectrum’s 23rd affiliation since 2017.

The practice is an outstanding addition to our growing network in the Lehigh Valley region, which includes Valley Eye Surgery Center (VESC), in Bethlehem. Dr. Bausch has been one of our highly regarded partner surgeons at VESC the premier, eye surgery only surgery center, serving the Lehigh Valley community. All our partners at VESC are proud to work with Dr. Bausch and his lay management team. We look forward to our continued delivery of exceptional eye care at Bausch Eye Associates, OCLI Vision and VESC, along with our esteemed partners at Lehigh Valley Eye Center|OCLI Vision, also located in Allentown.”

The experienced team at Bausch Eye Associates provides first-class patient focused care across various ophthalmic disciplines. The office is located at 1616 West Allen Street in Allentown, PA.

“OCLI Vision is known for their tremendous work in the ophthalmic field. Aligning with such a great group will allow us to provide even higher levels of care to the patients we dutifully serve,” noted Dr. Bausch.

For questions or further information regarding the OCLI Vision team or Spectrum Vision Partners, please contact:

Tom Burke

Chief Executive Officer

tburke@spectrumvisionpartners.com

Greg Wappett

Chief Development Officer

gwappett@spectrumvisionpartners.com

About OCLI Vision

Founded in 1997, OCLI Vision (http://www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.

About Spectrum Vision Partners

Spectrum Vision Partners (SVP) (http://www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With nearly 1,400 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 40 clinic locations, five state-licensed ambulatory surgery centers, and over 125 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.

About Blue Sea Capital

Blue Sea Capital (http://www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies valued up to $250 million. The firm has more than $750 million in assets under management and invests across three industry verticals: aerospace & defense, healthcare, and industrial growth. Blue Sea Capital’s strategy is to partner with talented managers and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.

Share article on social media or email:

Nationwide Texas Roadhouse and Bubba’s 33 Fundraiser to Benefit the American Tinnitus Association


News Image

“We are sincerely committed to supporting ATA’s mission to raise tinnitus awareness, fund research, and help people who are suffering. Texas Roadhouse and our family of Roadies are proud to honor the life and vision of our Founder Kent Taylor, who was passionate about helping others.”

On Monday, February 6, all Texas Roadhouse and Bubba’s 33 locations will donate 100 percent of the day’s profits to the American Tinnitus Association (ATA) in honor of the company’s late founder, Kent Taylor. The public is invited to show their support by dining (or ordering to-go) at any Texas Roadhouse or Bubba’s 33 location on February 6, which marks the first day of Tinnitus Awareness Week. The week pays tribute to the challenges faced by more than 26 million adults in the United States who experience tinnitus, an audiological and neurological condition often referred to as “ringing in the ears.” The condition can be mild, moderate, or severe, resulting in reduced quality of life and well-being, depending on the severity.

In addition to the restaurant fundraiser, Texas Roadhouse will sell ATA-branded gift cards through March 31 and donate 10 percent of online sales from those cards to the ATA. The gift cards are available online at texasroadhouse.com.

“Our partnership with Texas Roadhouse and Bubba’s 33 enables the ATA to advance tinnitus research through increased grant funding, as well as patient support services,” says David Hadley, chair of the ATA Board of Directors. “We are extraordinarily grateful to have the opportunity to raise awareness of tinnitus with Texas Roadhouse and Bubba’s 33, because, despite its prevalence, tinnitus remains a poorly understood condition among the public and is severely underfunded. Our partnership helps us raise awareness of the millions of people with tinnitus and brings us closer to finding meaningful relief for them.”

Texas Roadhouse CEO and President Jerry Morgan shares, “We are sincerely committed to supporting the ATA’s mission to raise awareness of tinnitus, fund research, and help people who are suffering. Texas Roadhouse and our family of Roadies honor the life and vision of our Founder Kent Taylor, who was passionate about helping others.”

About participating organizations:

The ATA is a nonprofit organization dedicated exclusively to serving the tinnitus community. The ATA helps individuals and families cope, provides guidance on finding qualified healthcare providers to assist in tinnitus management, funds research, advocates for better care, and provides trustworthy information to thousands of people every day. If you or a loved one need information or help managing tinnitus, contact the ATA at (800) 634-8978 or visit ata.org.

Based in Louisville, Kentucky, Texas Roadhouse opened its doors in 1993 and has more than 680 locations in 49 states and 10 foreign countries. The family-friendly restaurant is famous for hand-cut steaks, made-from-scratch sides, fresh-baked bread, and a lively atmosphere. In 2020, Texas Roadhouse was named one of America’s Best Employers for Veterans by Forbes. Texas Roadhouse also ranked sixth on FSR magazine’s Top 50 list of Full-Service Restaurants within the US. For more information, visit http://www.texasroadhouse.com/gift-cards.

Bubba’s 33 serves up a variety of menu options featuring handcrafted pizza, bold burgers, and ice-cold beer. The first Bubba’s 33 opened in Fayetteville, North Carolina, in 2013 and has grown to 37 locations in 14 states. Bubba’s 33 staff is dedicated to providing the best service in town and having fun. In 2021, Bubba’s 33 was named the Best Burger in Charlotte, NC. For more information, visit http://www.bubbas33.com.

Share article on social media or email:

Farlong Nutraceutical Concludes 90-Day Clinical Study to Determine Safety and Efficacy of Cognitive Health Supplement, Farlong Lifeflower® Breviscapine


News Image

Results from Farlong’s 90-day clinical study to determine safety and effectiveness of Farlong Lifeflower® Breviscapine

The expert panel committee concluded that Lifeflower® enhances the pharmacological effects of Erigeron Breviscapus and its active ingredients for the treatment of Alzheimer’s disease, metabolism, and the pharmacological mechanisms of active ingredients.

Farlong Nutraceutical, a vertically integrated, plant-based ingredient and supplement company, conducted a 90-day double blind, randomized, placebo controlled, parallel study to determine the safety and efficacy of Farlong Lifeflower® Breviscapine on improving long and short-term memory, concentration, and clarity of thinking in healthy individuals.

Conducted by clinician Melanie Montgomery, Ph.D., of Clinical Studies USA, the partially grant-funded study consisted of 160 healthy individuals divided into four study groups, with the first given one placebo capsule twice daily, and the other three groups receiving different daily doses of Farlong Lifeflower® Breviscapine – 100 mg, 200 mg, and 400 mg each. Every 30 days, subjects were given three separate evaluations to assess their cognitive thinking, concentration, clarity of thought and general brain functions, along with having vital signs checked and bloodwork analyzed.

Upon conclusion of the 90-day period, an expert panel committee concluded that Lifeflower® Breviscapine was shown to be safe, effective, and well tolerated with no negative impact on any organs or systems, and no interactions, sensitivities, or side effects reported during the study. The expert panel committee concluded that Lifeflower® enhances the pharmacological effects of Erigeron Breviscapus and its active ingredients for the treatment of Alzheimer’s disease, metabolism, and the pharmacological mechanisms of active ingredients.

The most significant positive impacts were seen in the MEM Trax cognitive thinking tests that were given – a psychological test designed to measure a person’s cognitive abilities and intellectual potential that was developed to test the type of memory most associated with Alzheimer’s disease and dementia. Participants also experienced positive changes over the 90 days in their A1c; Mini-Mental Status Exam (MMSE), a cognitive screening tool that provides a brief, objective measure of cognitive function; and during their Montreal Cognitive Assessment (MoCA), a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care.

The study was also peer-reviewed by M. Rubin MD, who believes the results are accurate and supported scientifically, making Lifeflower® Breviscapine a safe and effective product for human uses. He concluded that this study designates the best dose for Lifeflower® Breviscapine and that all necessary blood work was completed to indicate this product should produce no significant side effects.

Lifeflower® Breviscapine is an active flavonoid component extracted from Erigeron Breviscapus, containing more than 90 percent of scutellarin. Scutellarin has been shown to enhance memory, cognitive function and brain health; increase brain circulation; and promote the development of new blood vessels. A series of safety and efficacy studies were conducted, and an expert panel committee concluded that Lifeflower® Breviscapine manufactured consistent with cGMP (Current Good Manufacturing Practice) is GRAS (generally recognized as safe) for use as an ingredient in yogurt, nutritional bars, smoothies at 84 mg per serving, and dietary supplements at 200 mg per person per day.

Additional Farlong ingredient studies:

Farlong recently completed a 30-day double blind, randomized placebo-controlled, study to determine the safety and effectiveness of InnerPure® Colon Detox , which found that 100% of subjects experienced positive and healthy improvements in their daily bowel movements and the subjects on InnerPure® lost an average of four to five pounds during the 30-day study. In 2020, the company completed a three-year clinical trial in North America to determine the effects of Ginseng Plus® Panax Notoginseng™ extract, which demonstrated that Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract) supplementation was well tolerated and may have a positive influence on reducing the risk of cardiovascular disease by improving blood pressure and HDL-C. The trial results are published in a peer-reviewed medical journal, Current Nutraceuticals Journal by Bentham Science.

About Farlong Nutraceutical:

Farlong is a science-based and vertically integrated functional ingredient and formula provider who has more than 24 years of experience focusing on discovering, developing, and providing safe, effective, and unique medicinal herbs, plant extracts, and formulas with its own GAP (Good Agricultural Practice) certified cultivation base, cGMP (Current Good Manufacturing Practice) certified manufacturing facilities and distribution channels. Combining ancient Oriental medicine and modern technology, Farlong develops its own line of natural supplement brands, while offering contract manufacturing services and ingredients for health and beauty companies to create proprietary formulas and product lines. For more information, visit Farlong.com for supplements and 400+ ingredients, and follow on Facebook, Twitter and Instagram.

Share article on social media or email:



DuPont to Highlight Healthcare Portfolio, Medical Device Partnerships at MD&M West


News Image

“From concepting to commercialization, we support an ecosystem of medical device partners and work with them to create smarter next-generation devices.”

DuPont (NYSE:DD) today announced that it will highlight DuPont™ Liveo™ Healthcare Solutions – with an emphasis on the brand’s medical device product lines – at MD&M West 2023, which will take place Feb. 7-9 in Anaheim, California.

In Booth 3207, DuPont will feature its product portfolio – including new low-cyclic soft skin adhesive – and highlight medical device product partnerships, notably:


  • Nighthawk wearable patch – A collaboration with the Holst Centre that leverages the expanding portfolio of DuPont™ Liveo™ medical adhesives and sensing technologies to support the development of a wearable concept patch especially designed to improve wearability and long-term comfort, enhancing the patient experience while reliably recording electrical signals for vital signs and physiological parameters.
  • AeviceMD smart stethoscope – A collaboration with Aevice Health Pte Ltd. to support the development of a smart AI wearable stethoscope that provides continuous, connected care for at-home monitoring and early detection of asthma exacerbation (commonly referred to as an “asthma attack”) in patients.

“From concepting to commercialization, we support an ecosystem of medical device partners and work with them to create smarter next-generation devices,” said Liveo™ Healthcare Solutions Americas Marketing Leader Diana Salvadori. “Whether customers are looking for technological expertise; regulatory support; or a broad selection of high-quality, medical-grade materials that are easy to process and patient-friendly, DuPont serves a broad spectrum of medical device applications.”

DuPont™ is introducing new Liveo™ MG 7-9960 Soft Skin Adhesive, a soft elastomeric silicone adhesive for adhering medical devices to the skin with high adhesion force, long wear time, and gentle removal. The product has been designed with low content cyclosiloxanes.

Over the last 70-plus years, DuPont – a trusted partner in the medical device industry – has developed a leadership position within the industry by building upon foundational capabilities that serve the highly regulated healthcare market.

“We’re actively working to expand our portfolio of solutions to help customers meet challenging application demands for connected wearable devices,” Salvadori said.

DuPont’s medical device development partnerships and continued investments in its product portfolio and manufacturing expansion cement the company’s commitment to serving the healthcare market by offering high-quality, high-performance solutions; application and material science expertise; and strong regulatory support. Learn more about DuPont™ Liveo™ Healthcare Solutions at liveo.dupont.com.

About DuPont™ Liveo™ Healthcare Solutions

DuPont™ Liveo™ is a globally recognized leader in technology for a broad range of innovations in medical devices, biopharmaceutical processing, and pharmaceutical solutions. DuPont high-performance materials help create safer healthcare environments and protect the health of patients and healthcare providers worldwide. We help enable smarter healthcare and positive patient outcomes. More information can be found at liveo.dupont.com.

About DuPont Electronics & Industrial

DuPont Electronics & Industrial is a global supplier of new technologies and performance materials serving the semiconductor, circuit board, display, digital and flexographic printing, healthcare, aerospace, industrial, and transportation industries. From advanced technology centers worldwide, teams of talented research scientists and application experts work closely with customers, providing solutions, products, and technical service to enable next-generation technologies.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare, and worker safety. More information about the company, its businesses, and solutions can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

# # #

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

02/02/23

Share article on social media or email: